361 related articles for article (PubMed ID: 21880579)
1. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
Doberstein K; Pfeilschifter J; Gutwein P
Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
[TBL] [Abstract][Full Text] [Related]
2. L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells.
Doberstein K; Wieland A; Lee SB; Blaheta RA; Wedel S; Moch H; Schraml P; Pfeilschifter J; Kristiansen G; Gutwein P
Carcinogenesis; 2011 Mar; 32(3):262-70. PubMed ID: 21097529
[TBL] [Abstract][Full Text] [Related]
3. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
Lee SB; Schramme A; Doberstein K; Dummer R; Abdel-Bakky MS; Keller S; Altevogt P; Oh ST; Reichrath J; Oxmann D; Pfeilschifter J; Mihic-Probst D; Gutwein P
J Invest Dermatol; 2010 Mar; 130(3):763-73. PubMed ID: 19865098
[TBL] [Abstract][Full Text] [Related]
4. PAX2 may induce ADAM10 expression in renal tubular epithelial cells and contribute to epithelial-to-mesenchymal transition.
Hou L; Du Y; Zhao C; Wu Y
Int Urol Nephrol; 2018 Sep; 50(9):1729-1741. PubMed ID: 30117015
[TBL] [Abstract][Full Text] [Related]
5. PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells.
Lee SB; Doberstein K; Baumgarten P; Wieland A; Ungerer C; Bürger C; Hardt K; Boehncke WH; Pfeilschifter J; Mihic-Probst D; Mittelbronn M; Gutwein P
PLoS One; 2011; 6(8):e22312. PubMed ID: 21876729
[TBL] [Abstract][Full Text] [Related]
6. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth.
Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K
Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880
[TBL] [Abstract][Full Text] [Related]
7. Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity.
Riedle S; Kiefel H; Gast D; Bondong S; Wolterink S; Gutwein P; Altevogt P
Biochem J; 2009 May; 420(3):391-402. PubMed ID: 19260824
[TBL] [Abstract][Full Text] [Related]
8. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
Liu S; Zhang W; Liu K; Ji B; Wang G
Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
[TBL] [Abstract][Full Text] [Related]
9. Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10.
Prox J; Willenbrock M; Weber S; Lehmann T; Schmidt-Arras D; Schwanbeck R; Saftig P; Schwake M
Cell Mol Life Sci; 2012 Sep; 69(17):2919-32. PubMed ID: 22446748
[TBL] [Abstract][Full Text] [Related]
10. Amyloid precursor protein regulates migration and metalloproteinase gene expression in prostate cancer cells.
Miyazaki T; Ikeda K; Horie-Inoue K; Inoue S
Biochem Biophys Res Commun; 2014 Sep; 452(3):828-33. PubMed ID: 25218471
[TBL] [Abstract][Full Text] [Related]
11. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
[TBL] [Abstract][Full Text] [Related]
13. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
Gutwein P; Schramme A; Sinke N; Abdel-Bakky MS; Voss B; Obermüller N; Doberstein K; Koziolek M; Fritzsche F; Johannsen M; Jung K; Schaider H; Altevogt P; Ludwig A; Pfeilschifter J; Kristiansen G
Eur J Cancer; 2009 Feb; 45(3):478-89. PubMed ID: 19070478
[TBL] [Abstract][Full Text] [Related]
14. An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin.
Lo Sardo V; Zuccato C; Gaudenzi G; Vitali B; Ramos C; Tartari M; Myre MA; Walker JA; Pistocchi A; Conti L; Valenza M; Drung B; Schmidt B; Gusella J; Zeitlin S; Cotelli F; Cattaneo E
Nat Neurosci; 2012 May; 15(5):713-21. PubMed ID: 22466506
[TBL] [Abstract][Full Text] [Related]
15. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.
Gavert N; Sheffer M; Raveh S; Spaderna S; Shtutman M; Brabletz T; Barany F; Paty P; Notterman D; Domany E; Ben-Ze'ev A
Cancer Res; 2007 Aug; 67(16):7703-12. PubMed ID: 17699774
[TBL] [Abstract][Full Text] [Related]
16. Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma.
Gaida MM; Haag N; Günther F; Tschaharganeh DF; Schirmacher P; Friess H; Giese NA; Schmidt J; Wente MN
Int J Mol Med; 2010 Aug; 26(2):281-8. PubMed ID: 20596609
[TBL] [Abstract][Full Text] [Related]
17. L1 stimulation of human glioma cell motility correlates with FAK activation.
Yang M; Li Y; Chilukuri K; Brady OA; Boulos MI; Kappes JC; Galileo DS
J Neurooncol; 2011 Oct; 105(1):27-44. PubMed ID: 21373966
[TBL] [Abstract][Full Text] [Related]
18. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.
Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K
Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943
[TBL] [Abstract][Full Text] [Related]
19. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma.
Ko SY; Lin SC; Wong YK; Liu CJ; Chang KW; Liu TY
Cancer Lett; 2007 Jan; 245(1-2):33-43. PubMed ID: 16309826
[TBL] [Abstract][Full Text] [Related]
20. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
